The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 11, 2022

Filed:

Aug. 21, 2020
Applicant:

Hoffmann-la Roche Inc., Little Falls, NJ (US);

Inventors:

Lykke Pedersen, Horsholm, DK;

Hassan Javanbakht, Basel, CH;

Malene Jackerott, Horsholm, DK;

Søren Ottosen, Horsholm, DK;

Souphalone Luangsay, Basel, CH;

Assignee:

HOFFMANN-LA ROCHE INC., Little Falls, NJ (US);

Attorney:
Int. Cl.
CPC ...
C12N 15/11 (2006.01); C07K 16/28 (2006.01); C12N 15/113 (2010.01); A61K 38/17 (2006.01); A61K 39/39 (2006.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/28 (2013.01); A61K 38/1709 (2013.01); A61K 39/39 (2013.01); A61K 39/39558 (2013.01); C12N 15/1138 (2013.01); A61K 45/06 (2013.01); A61K 2039/505 (2013.01); A61K 2039/55516 (2013.01); A61K 2039/572 (2013.01); C07K 2317/70 (2013.01); C12N 2310/11 (2013.01); C12N 2310/315 (2013.01); C12N 2310/3231 (2013.01); C12N 2310/341 (2013.01); C12N 2310/346 (2013.01); C12N 2310/351 (2013.01); G01N 2800/26 (2013.01); Y02A 50/30 (2018.01);
Abstract

The present invention relates to antisense oligonucleotides that are capable of reducing expression of PD-L1 in a target cell. The oligonucleotides hybridize to PD-L1 mRNA. The present invention further relates to conjugates of the oligonucleotide and pharmaceutical compositions and methods for treatment of viral liver infections such as HBV, HCV and HDV; parasite infections such as malaria, toxoplasmosis, leishmaniasis and trypanosomiasis or liver cancer or metastases in the liver using the oligonucleotide.


Find Patent Forward Citations

Loading…